Explore more publications!

CBP seizes more than $1.2 million in assorted narcotics at Anzalduas International Bridge

MISSION, Texas—U.S. Customs and Border Protection Office of Field Operations officers at the Anzalduas International Bridge seized $1,119,000 worth of alleged cocaine, $54,000 of alleged fentanyl and $87,000 of alleged heroin in two separate incidents over the weekend.

CBP seizes $1.2 million in narcotics.

“Our CBP officers’ expertise with our tools and technology is second to none,” said Port Director Carlos Rodriguez, Port of Hidalgo/Pharr/Anzalduas.

On Jan. 17, CBP officers encountered a RAM 1500 attempting to make entry to the U.S. from Mexico. The vehicle was selected for further review utilizing nonintrusive inspection equipment and a canine team. Physical inspection led to the discovery of 14 packages of alleged cocaine with a combined weight of 32.18 pounds concealed within the vehicle.

The following day, CBP officers encountered a Ford sedan attempting to make entry to the U.S. from Mexico. The vehicle was selected for further inspection utilizing nonintrusive inspection equipment and a canine team. Physical inspection led to the discovery of 22 packages of alleged cocaine with a combined weight of 52.07 pounds, one package of alleged fentanyl with a weight of 2.33 pounds and two packages of alleged heroin with a combined weight of 4.58 pounds concealed within the vehicle.

CBP seized the narcotics and vehicles. Homeland Security Investigations Special Agents arrested the drivers and initiated criminal investigations.

Follow the Director of CBP’s Laredo Field Office on X @DFOLaredo  and Instagram @dfolaredo as well as U.S. Customs and Border Protection at X @CBPSouthTexas  for breaking news, current events, human interest stories and photos.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions